STAT

Trump’s administration is rewriting a rule that made transgender health care accessible. Patients are scared

The Trump administration is revising a requirement that states cover transgender care in their Medicaid programs. Transgender patients are terrified.

LOS ANGELES — Jyn Dao is scared. His bottom surgery — needed to realign the female genitalia he was born with to his male identity — is scheduled. But it’s not happening until January. And like many trans men and women, he’s afraid President Trump will soon revoke protections in federal law that ensure his surgery is affordable.

“Me, my friends, people in the trans community, we’re really worried,” said Dao, a 25-year-old Vietnamese-American who has been slowly transitioning his gender over the past decade.

If insurance coverage disappears, he added,  “a lot of people are going to be trapped in their bodies — including me.”

Republicans in Congress have not been able to overturn the Affordable Care Act — at least, not yet. But the Trump administration is working to revise a section of the law that says federally funded health programs cannot discriminate on the basis of sex.

The Obama administration made clear that this provision required states to cover transgender care through their Medicaid programs. Now, however, Health and Human Services Secretary Tom Price has told that he’s reworking the rule and in the meantime.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks